Compare Cytokinetics Inc (CYTK) vs Frontline Plc Ordinary Shares (FRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Frontline Plc Ordinary Shares — how do they compare? Cytokinetics Inc trades at $62.91 (market cap $8.62B), while Frontline Plc Ordinary Shares trades at $56.1 (market cap $12.52B). The key difference: Frontline Plc Ordinary Shares is the larger of the two by market cap, and Frontline Plc Ordinary Shares pays a 9.56% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Frontline Plc Ordinary Shares for 0 Days on average.
| CYTK | FRO | |
|---|---|---|
Market Cap | $8.62B | $12.52B |
Volume | 2,594,626 | 6,375,509 |
Sector | Health | Industrials |
52-Week High | $87.26 | $56.26 |
52-Week Low | $54.76 | $20.58 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | $8.72B | $14.64B |
Dividend Yield | — | 9.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $62.01, up 1.46% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported Q2 2026 EPS of -$1.50, beating expectations, but maintains deeply negative profitability with a net income margin of -1,321.12% for 2026. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy studies and presentations at major medical conferences.
Wall Street sentiment is overwhelmingly bullish with a 97.14% buy rating and a $112.60 consensus price target, signaling strong upside potential. However, high cash burn, substantial losses, and significant debt-to-asset ratio of 81.23% present substantial financial risks. Investment appeal hinges on successful commercialization of its pipeline amid intense competition.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Frontline Plc Ordinary Shares
Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.
Read more on FRO →
